Video

Screening Opportunities and Policy Updates in HCV

Author(s):

Parvez Mantry, MD,Mamta Jain, MD, MPH

Parvez Mantry, MD, examines the question of why so many patients with HCV do not undergo therapy. He also discusses policy updates aimed at improving screening and expanding access to treatment.

Related Videos
Chari Cohen, DrPH, MPH | Credit: LinkedIn
Zoi Papalamprakopoulou, MD | Credit: Papalamprakopoulou on LinkedIn
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Age, Race, Ethnicity Disparities Hinder Celiac Disease Screening, with Debra Silberg, MD, PhD
Related Content
Esi Lamousé-Smith, MD, PhD | Credit: Johnson & Johnson
November 22nd 2024

J&J Submits sBLA for Guselkumab (Tremfya) Subcutaneous Induction Regimen in UC

Abigail Brooks, MA
Innovations in GERD: What Vonoprazan (Voquezna) May Offer Over PPIs, with Adelina Hung, MD
July 18th 2024

Innovations in GERD: What Vonoprazan (Voquezna) May Offer Over PPIs, with Adelina Hung, MD

Abigail Brooks, MA
Laura Hamant, MD: Standardized Algorithm Increases VTE Prophylaxis Among Children
November 19th 2024

Laura Hamant, MD: Standardized Algorithm Increases VTE Prophylaxis Among Children

Chelsie Derman
Bindu Anand Balani, MD: Eradicating Hepatitis C Virus by 2030
July 28th 2022

Bindu Anand Balani, MD: Eradicating Hepatitis C Virus by 2030

Kenny Walter
Mariana Nunes Ferreira, MD | Credit: Mariana Nunes Ferreira on X
November 16th 2024

Vitamin D Deficiency Linked to Worse Autoimmune Hepatitis Outcomes

Abigail Brooks, MA
Nadege Pelletier, PhD | Credit: Barinthus Bio
November 15th 2024

VTP-300, Nivolumab Combination Shows Promise for Functional HBV Cure in Phase 2b Trial

Abigail Brooks, MA
© 2024 MJH Life Sciences

All rights reserved.